 |
|
Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
Systematic Review and Meta-analysis
Matthew J. Taylor, MRCPsych;
Nick Freemantle, PhD;
John R. Geddes, MD;
Zubin Bhagwagar, DPhil
Arch Gen Psychiatry. 2006;63:1217-1223.
Context Selective serotonin reuptake inhibitors (SSRIs) are often described as having a delayed onset of effect in the treatment of depression. However, some trials have reported clinical improvement as early as the first week of treatment.
Objective To test the alternative hypotheses of delayed vs early onset of antidepressant action with SSRIs in patients with unipolar depression.
Data Sources Trials identified by searching CENTRAL, The Cochrane Collaboration database of controlled trials (2005), and the reference lists of identified trials and other systematic reviews.
Study Selection Randomized controlled trials of SSRIs vs placebo for the treatment of unipolar depression in adults that reported outcomes for at least 2 time points in the first 4 weeks of treatment (50 trials from >500 citations identified). Trials were excluded if limited to participants older than 65 years or specific comorbidities.
Data Extraction Data were extracted on trial design, participant characteristics, and outcomes by a single reviewer.
Data Synthesis Pooled estimates of treatment effect on depressive symptom rating scales were calculated for weeks 1 through 6 of treatment. In the primary analysis, the pattern of response seen was tested against alternative models of onset of response. The primary analysis incorporated data from 28 randomized controlled trials (n = 5872). A model of early treatment response best fit the experimental data. Treatment with SSRIs rather than placebo was associated with clinical improvement by the end of the first week of use. A secondary analysis indicated an increased chance of achieving a 50% reduction in Hamilton Depression Rating Scale scores by 1 week (relative risk, 1.64; 95% confidence interval, 1.2-2.25) with SSRI treatment compared with placebo.
Conclusions Treatment with SSRIs is associated with symptomatic improvement in depression by the end of the first week of use, and the improvement continues at a decreasing rate for at least 6 weeks.
Author Affiliations: Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, England (Drs Taylor and Geddes); Department of Psychiatry, Yale University School of Medicine, New Haven, Conn (Dr Bhagawar); and Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham, England (Dr Freemantle).
RELATED LETTER
Publication Bias in Systematic Reviews
Corrado Barbui and Andrea Cipriani
Arch Gen Psychiatry. 2007;64(7):868.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Abnormal temporal difference reward-learning signals in major depression
Kumar et al.
Brain 2008;0:awn136v1-awn136.
ABSTRACT
| FULL TEXT
Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials
Barbui et al.
CMAJ 2008;178:296-305.
ABSTRACT
| FULL TEXT
Major Depressive Disorder
Belmaker and Agam
NEJM 2008;358:55-68.
FULL TEXT
Review: Response to SSRIs in unipolar depression occurs in the first week of treatment
Kennedy
Evid. Based Ment. Health 2007;10:81-81.
FULL TEXT
Publication Bias in Systematic Reviews
Barbui and Cipriani
Arch Gen Psychiatry 2007;64:868-868.
FULL TEXT
Review: SSRIs lead to improvement in depression by the end of the first week
Wilson
Evid. Based Med. 2007;12:72-72.
FULL TEXT
Onset of action of antidepressants
Tylee and Walters
BMJ 2007;334:911-912.
FULL TEXT
SSRIs start to relieve depression soon after the start of treatment
BMJ 2006;333:.
ABSTRACT
| FULL TEXT
|
